Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 41 (4), 1049-1054
- https://doi.org/10.1038/ki.1992.159
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pharmacokinetics of Calcitriol in Continuous Ambulatory and Cycling Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1990
- Carbohydrate metabolism in uremiaPediatric Nephrology, 1989
- Rapid Normalization/Stimulation by 1,25- Dihydroxyvitamin D3of Insulin Secretion and Glucose Tolerance in the Vitamin D-Deficient Rat*Endocrinology, 1987
- Demonstration that the Vitamin D Metabolite 1,25(OH)2-Vitamin D3 and Not 24R,25(OH)2-Vitamin D3 Is Essential for Normal Insulin Secretion in the Perfused Rat PancreasDiabetes, 1985
- The Influence of Hyperparathyroidism on Glucose Metabolism in Uremia*Journal of Clinical Endocrinology & Metabolism, 1985
- Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas.Journal of Clinical Investigation, 1984
- Circulating vitamin D metabolite concentrations in childhood renal diseasesKidney International, 1982
- Vitamin D Deficiency Inhibits Pancreatic Secretion of InsulinScience, 1980
- Effects of arterial versus venous sampling on analysis of glucose kinetics in manJournal of Applied Physiology, 1976
- Intravenous Glucose Tolerance as a Tool in Definition and Diagnosis of Diabetes MellitusBMJ, 1962